About this trial
RATIONALE: To improve strategies for detection and prevention of early-stage disease.
PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.
Eligibility criteria
Qualifiers
Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer
Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor
A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer
Increased risk as deemed by a certified genetic counselor
Disqualifiers
None
Trial design
Treatments tested in this trial
- Ca-125
- screening questionnaire administration
- Surgery
Treatment groups
Sponsors and collaborators
Northwestern University
Lead sponsor
National Cancer Institute (NCI)
Collaborator